Unlock instant, AI-driven research and patent intelligence for your innovation.

Non-Absorbent Articles Including Aromatic Compositions As Inhibitors Of Exoprotein Production

a non-absorbent, non-absorbent technology, applied in the direction of bandages, biocide, animal husbandry, etc., can solve the problems of difficult to eradicate i>s. aureus /i>bacterium without harming members, and the use of antibiotics that kill i>s. aureus /i>is not an option in products, so as to inhibit the production of exoproteins

Inactive Publication Date: 2007-07-05
KIMBERLY-CLARK WORLDWIDE INC
View PDF12 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The aromatic compounds significantly reduce the production of TSST-1 and Enterotoxin B from S. aureus when applied to non-absorbent articles, maintaining the balance of natural vaginal flora and minimizing the impact of enzymes like lipase and esterase.

Problems solved by technology

Some microbial products produced in the vagina may negatively affect the human host.
When S. aureus is present in an area of the human body that harbors a normal microbial population such as the vagina, it may be difficult to eradicate the S. aureus bacterium without harming members of the normal microbial flora required for a healthy vagina.
Typically, antibiotics that kill S. aureus are not an option for use in products inserted into the vagina because of their effect on the normal vaginal microbial flora and their propensity to stimulate toxin production if all of the S. aureus are not killed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Non-Absorbent Articles Including Aromatic Compositions As Inhibitors Of Exoprotein Production
  • Non-Absorbent Articles Including Aromatic Compositions As Inhibitors Of Exoprotein Production
  • Non-Absorbent Articles Including Aromatic Compositions As Inhibitors Of Exoprotein Production

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0072] In this Example, the effect of various test compounds on the growth of S. aureus and the production of TSST-1 was determined. The test compound, in the desired concentration (expressed in percent of active compound) was placed in 10 mL of a growth medium in a sterile, 50 mL conical polypropylene tube (Sarstedt, Inc. Newton, N.C.).

[0073] The growth medium was prepared by dissolving 37 grams of brain heart infusion broth (BHI) (Difco Laboratories, Cockeysville, Md.) in 880 mL of distilled water and sterilizing the broth according to the manufacturer's instructions. The BHI was supplemented with fetal bovine serum (FBS) (100 mL) (Sigma Chemical Company, St. Louis, Mo.). Hexahydrate of magnesium chloride (0.021 M, 10 mL) (Sigma Chemical Company, St. Louis, Mo.) was added to the BHI-FBS mixture. Finally, L-glutamine (0.027 M, 10 mL) (Sigma Chemical Company, St. Louis, Mo.) was added to the mixture.

[0074] Compounds to be tested included phenylethyl alcohol, benzyl alcohol, and 2-...

example 2

[0081] In this Example, the effect of various test compounds on the growth of S. aureus and the production of TSST-1 was determined. The effect of the test compounds tested in Example 2 was determined by placing the desired concentration, expressed in percent of the active compound, in 10 mL of a growth medium as described in Example 1. The test compounds were then tested and evaluated as in Example 1.

[0082] In accordance with the present invention, Table 2 shows that S. aureus (MN8), when compared to the control, produced significantly less TSST-1 in the presence of the aromatic compounds. The aromatic compounds reduced the amount of exotoxin production ranging from about 82% to 97%. However, although the amount of toxin produced was significantly reduced, there was minimal, if any, effect on the growth of S. aureus cells.

TABLE 2ELISA:% TestTSST-1ReductionCom-Opticalng / ODofCompoundpoundDensityCFU / mLunitToxin %Growth MediumZero0.607>1.6E+09  2424N / AMethanol400 μL0.5982.6E+092690N...

example 3

[0083] In this Example, the effect of various test compounds on the growth of S. aureus and the production of TSST-1 was determined. The effect of the test compounds tested in Example 3 was determined by placing the desired concentration, expressed in percent of the active compound, in 10 mL of a growth medium as described in Example 1. The test compounds were then tested and evaluated as in Example 1.

[0084] In accordance with the present invention, Table 3 shows that S. aureus (MN8), when compared to the control, produced significantly less TSST-1 in the presence of the aromatic compounds. The aromatic compounds reduced the amount of exotoxin production ranging from about 69% to 98%. However, although the amount of toxin produced was significantly reduced, there was minimal, if any, effect on the growth of S. aureus cells.

TABLE 3ELISA:TSST-1% TestOpticalng / ODReductionCompoundCompoundDensityCFU / mLunitof Toxin %GrowthZero0.6273.9E+091931N / AMediumMethanol100 uL0.5885.2E+092041N / APh...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
pHaaaaaaaaaa
volumesaaaaaaaaaa
Login to View More

Abstract

Non-absorbent articles are disclosed. The non-absorbent articles include an effective amount of an aromatic inhibitory compound to substantially inhibit the production of exotoxins by Gram positive bacteria. The aromatic inhibitory compounds of the present invention have the general formula: wherein R1 is selected from the group consisting of H, and NH2 and salts thereof; R5 is a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety; R6 is a divalent saturated or unsaturated aliphatic hydrocarbyl moiety; R7 is a trivalent saturated or unsaturated aliphatic hydrocarbyl moiety; R8 is a monovalent substituted or unsubstituted saturated or unsaturated aliphatic hydrocarbyl moiety which may or may not be interrupted with hetero atoms; R2, R3, and R4 are independently selected from the group consisting of H, OH, COOH, and —C(O)R9; R9 is hydrogen or a monovalent saturated or unsaturated aliphatic hydrocarbyl moiety.

Description

CROSS-REFERENCE TO RELATED APPLICATION [0001] This application is a divisional of U.S. patent application Ser. No. 10 / 803,345, filed Mar. 18, 2004, which is a divisional patent application claiming priority from U.S. patent application Ser. No. 09 / 969,391 filed on Oct. 2, 2001, the entireties of which are hereby incorporated by reference.BACKGROUND OF THE INVENTION [0002] The present invention relates to the inhibition of exoprotein production in association with a non-absorbent article. More particularly, the present invention relates to the coating or treatment of certain aromatic compounds onto non-absorbent articles and the effects of these compounds on Gram positive bacteria. [0003] There exists in the female body a complex process which maintains the vagina and physiologically related areas in a healthy state. In a female between the age of menarche and menopause, the normal vagina provides an ecosystem for a variety of microorganisms. Bacteria are the predominant type of micr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/325A61K31/165A61K8/73A61L15/46
CPCA61K31/165A61K31/325A61L15/46A61L2300/402A61L2300/404A61L2300/41A61L2300/45A61L2300/802
Inventor SYVERSON, RAEPROCTOR, RICHARD
Owner KIMBERLY-CLARK WORLDWIDE INC